| 0.5-year LC rate (%) | 1-year LC rate (%) | 2-year LC rate (%) | P value |
---|---|---|---|---|
BED10 (Gy) | ||||
 ▪ < 75 | 85.7 | 66.7 | 66.7 | 0.260 |
 ▪ ≥ 75 | 90.0 | 90.0 | 90.0 |  |
Prescription dose (Gy) | ||||
 ▪ < 41.6 | 84.6 | 63.5 | 63.5 | 0.179 |
 ▪ ≥ 41.6 | 90.9 | 90.9 | 90.9 |  |
GTV (ml) | ||||
 ▪ < 34.5 | 100 | 92.3 | 92.3 | 0.039 |
 ▪ ≥ 34.5 | 72.7 | 58.2 | 58.2 |  |
Gender | ||||
 ▪ Male | 85.0 | 72.9 | 72.9 | 0.268 |
 ▪ Female | 100 | 100 | 100 |  |
Tracking method | ||||
 ▪ Synchrony respiratory motion | 100 | 100 | 100 | 0.461 |
 ▪ X-sight spine | 84.6 | 75.6 | 75.6 |  |
Location of AGMs | ||||
 ▪ Left | 100 | 80 | 80 | 0.860 |
 ▪ Right | 84.2 | 77.7 | 77.7 |  |
Systemic therapy | ||||
 ▪ Yes | 87.5 | 87.5 | 87.5 | 0.492 |
 ▪ None | 87.5 | 72.9 | 72.9 |  |
SBRT for other sites | ||||
 ▪ Yes | 100 | 100 | 100 | 0.056 |
 ▪ None | 78.6 | 64.3 | 64.3 |  |